← Eichor
Study identifier: NCT04052022 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Paradoxical Tuberculosis Reactions in Patients Without HIV Infection

Condition: Tuberculosis  ·  Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

PhaseN/A
Planned participants140
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersNo

About this study

Background: Most people with tuberculosis (TB) feel better after starting treatment. But for some people, the opposite happens. They may feel better at first, but then suddenly get worse. This is a paradoxical reaction. Researchers want to better understand what causes this reaction and what happens after someone has it. Objective: To learn about paradoxical reactions to TB treatment. Eligibility: Adults 18 and older diagnosed with confirmed or suspected TB and currently on treatment for at least 2 weeks, with or without signs/symptoms of a paradoxical inflammatory reaction. Design: Participants will be screened with a physical exam and medical history. They will give blood and urine samples. Eligible participants will visit either the NIH Clinical Center or the Mexico Clinic sites 3 times over 6 to 18 months. Each visit will take 7 hours to complete; visits may be scheduled over more than 1 day. Participants may have more visits if their TB symptoms change. Participants will give blood, urine, and sputum samples. They will have adverse event assessments. They will have 2 to 3 positron emission tomography/computed tomography (PET/CT) scans. PET/CT scans make pictures of the inside of the body. For this, participants will lie on a table that slides into a donut-shaped scanner. They will get a small amount of radioactive dye through an IV, which is a small plastic tube placed in a vein in the arm using a needle. Participants may have optional apheresis at the NIH site…

This description comes directly from the study's public registry record.

Talk to the study team

Mary E McLaughlin, R.N.  ·  (301) 435-8001  ·  mmclaughli@niaid.nih.gov

Maura M Manion, M.D.  ·  (301) 312-2103  ·  maura.manion@nih.gov

Always discuss trial participation with your own doctor first.

Locations (2)

National Institutes of Health Clinical CenterBethesda, Maryland, United StatesRecruiting
Mexican Emerging Infectious Diseases Clinical Research Network (LaRed)Alcaldia Tlalpan, MexicoRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04052022